#Disability

In a tale that echoes across decades, the latest discussions around autism research push back against blaming mothers for their children’s neurodevelopmental differences. A new wave of reporting and scientific consensus explicitly rejects the old notion that parental warmth, or the lack thereof, causes autism, and it reiterates that there is no reliable link between acetaminophen exposure during pregnancy or early life and autism. For Thai families navigating questions about their children’s development, the message is clear: science does not fault mothers, and effective support hinges on evidence-based care, early intervention, and compassionate communities rather than guilt or blame.

A wave of new research is spotlighting a quiet reality: millions of adults around the world may live with autism without ever receiving a formal diagnosis. The emerging picture centers on “camouflaging” or masking autistic traits—strategies used to hide social differences in daily life. While the conversation has often focused on children, these findings have immediate implications for adults, families, workplaces, and health systems in Thailand, where awareness and diagnostic pathways are still evolving.

A new wave of technological advances promises parents a chance to have “high-quality” families by screening embryos for optimal genetic health, but current research and social debate show that the quest for genetic perfection may come at significant ethical, cultural, and emotional costs. As genetic screening companies like Orchid promote the ability to select embryos free from a wide array of health risks, a chorus of bioethicists, parents, and social critics warn that this trend risks making children into consumer products and overlooks the unpredictability—and inherent value—of imperfect human lives (The Dispatch).

Recent advances in genetic screening give parents the option to choose embryos based on health profiles. While this could reduce certain illnesses, experts warn that chasing genetic perfection may bring ethical, cultural, and emotional costs for families and society. In Thailand, preimplantation genetic testing (PGT) is increasingly offered as an add-on in IVF, shifting the conversation from possibility to broader questions about value, diversity, and compassion.

Thailand stands at a crossroads of medical tourism and evolving social norms around family and reproduction. Policymakers and communities must weigh technological capability against cultural values, social equity, and acceptance of difference.

As Thailand’s healthcare system modernises and more children with complex health needs survive and thrive, a crucial question is gaining prominence: are we truly supporting the parents who shoulder the day-to-day care of sick or disabled children—or could we be unintentionally making their burden heavier? Echoing concerns raised in a recent commentary by The Guardian, leading-edge research highlights that while the journey of parenting often appears communal, families dealing with illness or disability travel a far lonelier, more taxing road that requires nuanced support from society, healthcare providers, and government systems (The Guardian).

A growing question in Thailand’s evolving health system is how to best support parents who care for children with chronic illness or disability. International studies echo a troubling finding: caregiving can take a heavy psychological toll on families, often leaving parents feeling isolated and overwhelmed.

For many Thai families, parenting a child with significant health needs means stepping off the traditional path. While new parents often rely on support networks, caregivers of chronically ill children frequently struggle to find empathy and practical help from family and friends.

A wave of recent research is challenging long-held beliefs about Attention Deficit Hyperactivity Disorder (ADHD), questioning whether the condition is truly a lifelong, biologically fixed disorder and whether the medical model that has dominated diagnosis and treatment actually serves those affected. With global ADHD diagnosis rates soaring and stimulant prescriptions at record levels—mirrored by rising numbers in Thailand—the debate over what ADHD is and how best to help children and adults affected is more urgent than ever. These new perspectives could have a profound impact not only on clinical practice in the West but on the evolving approach to ADHD in Thailand, where both awareness and skepticism about the condition are growing rapidly.